Edition:
United Kingdom

MacroGenics Inc (MGNX.OQ)

MGNX.OQ on NASDAQ Stock Exchange Global Select Market

21.82USD
23 May 2018
Change (% chg)

$0.10 (+0.46%)
Prev Close
$21.72
Open
$21.56
Day's High
$22.31
Day's Low
$21.56
Volume
46,984
Avg. Vol
130,305
52-wk High
$32.57
52-wk Low
$14.36

Chart for

About

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology... (more)

Overall

Beta: 2.78
Market Cap(Mil.): $659.43
Shares Outstanding(Mil.): 36.80
Dividend: --
Yield (%): --

Financials

  MGNX.OQ Industry Sector
P/E (TTM): -- 84.06 32.75
EPS (TTM): -4.18 -- --
ROI: -49.45 1.57 14.38
ROE: -52.35 2.43 16.07

BRIEF-MacroGenics Posts Qtrly Net Loss Per Common Share Of $1.34

* MACROGENICS PROVIDES UPDATE ON CORPORATE PROGRESS AND 1ST QUARTER 2018 FINANCIAL RESULTS

07 May 2018

BRIEF-Macrogenics Inc Prices Of Public Offering

* MACROGENICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

28 Mar 2018

BRIEF-Macrogenics Announces Proposed Public Offering Of Common Stock

* MACROGENICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

26 Mar 2018

BRIEF-Macrogenics Provides Update On Corporate Progress And 2017 Financial Results

* MACROGENICS PROVIDES UPDATE ON CORPORATE PROGRESS AND 2017 FINANCIAL RESULTS

27 Feb 2018

BRIEF-Macrogenics Enters Research Collaboration With Roche

* MACROGENICS ENTERS RESEARCH COLLABORATION WITH ROCHE TO DEVELOP A NOVEL BISPECIFIC MOLECULE

04 Jan 2018

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF219.25 -4.65
Roche Holding Ltd. (RO.S) CHF223.40 -5.40
Amgen, Inc. (AMGN.OQ) $179.94 +1.58
Xencor Inc (XNCR.OQ) $36.96 +0.72

Earnings vs. Estimates